Assess whether to re-trade, restructure, or drop after IT diligence showing
August 31, 2026
SITUATION QoE add-backs the seller marked 'normalized' arrived with IT diligence showing two ERPs and no chart of accounts map. Carve-out separation lead in a health-system acquiring a specialty practice still has an evidence gap on whether to re-trade, restructure, or drop.
DECISION Carve-out separation lead in a health-system acquiring a specialty practice must choose To re-trade, restructure, / Drop using QoE add-backs the seller marked 'normalized' after IT diligence showing two ERPs and no chart of accounts map.
HYPOTHESES TO TEST 1. QoE add-backs the seller marked 'normalized' reads as To re-trade, restructure, once IT diligence showing two ERPs and no chart of accounts map is lined up to the same M&A Due Diligence population. 2. QoE add-backs the seller marked 'normalized' is closer to Drop after IT diligence showing two ERPs and no chart of accounts map; To re-trade, restructure, would over-claim this People and Contracts extract. 3. A dual reading is still live in QoE add-backs the seller marked 'normalized' for carve-out separation lead in a health-system acquiring a specialty practice. 4. QoE add-backs the seller marked 'normalized' is missing the fact carve-out separation lead needs after IT diligence showing two ERPs and no chart of accounts map; stop this M&A Due Diligence close.
ANALYSIS REQUIRED 1. Map reps, earnout mechanics, and integration risk a health-system acquiring a specialty practice would inherit. 2. Tie quality-of-earnings, working-capital, and contingent items in QoE add-backs the seller marked 'normalized' to to re-trade, restructure, or drop. 3. Name the document carve-out separation lead still needs before signing. 4. For this M&A Due Diligence People and Contracts file, read QoE add-backs the seller marked 'normalized' against IT diligence showing two ERPs and no chart of accounts map and write the one fact that would move to re-trade, restructure, or drop for carve-out separation lead.
RECOMMENDATION Choose To re-trade, restructure, / Drop on this M&A Due Diligence / People and Contracts packet (QoE add-backs the seller marked 'normalized' after IT diligence showing two ERPs and no chart of accounts map). Lead with the M&A Due Diligence option QoE add-backs the seller marked 'normalized' can support after IT diligence showing two ERPs and no chart of accounts map, then the two facts that force it, then the Monday action for carve-out separation lead in a health-system acquiring a specialty practice.
COMMAND RETURNS - Bottom-line M&A Due Diligence option on to re-trade, restructure, or drop, then the evidence in QoE add-backs the seller marked 'normalized', then the action for carve-out separation lead - Hypothesis scorecard against QoE add-backs the seller marked 'normalized': supported / rejected / untestable - Regulatory or exam hook People and Contracts would cite - People and Contracts finding in QoE add-backs the seller marked 'normalized' that a second reviewer can re-perform
Explore more
More M&A Due Diligence prompts
- Assess whether management can run this without the founder (6cdb92)
- Assess whether to re-trade, restructure, or drop (a46036)
- Assess whether the carve-out is operable on day one after a contractor who
- Assess whether integration costs were sandbagged in the CIM (937e9c)
- Commercial-diligence partner must resolve whether working capital should be
Explore related decision areas
See governed multi-model AI on your own prompt
Compare GPT-5, Claude, and Gemini side by side, with human review and a decision record built in.

